Ann Dermatol.  2013 Feb;25(1):118-120. 10.5021/ad.2013.25.1.118.

Henoch-Schonlein Purpura during Isotretinoin Therapy

• Turan Y
• Cayirli M
• Tunca M

• KMID: 2265988
• DOI: http://doi.org/10.5021/ad.2013.25.1.118

Abstract

No abstract available.

MeSH Terms

Isotretinoin
Purpura, Schoenlein-Henoch
Isotretinoin

Figure

• 

  Fig. 1 Palpable purpuric lesions on the lower limbs

• 

  Fig. 2 (A) Dermal perivascular inflammatory infiltration (H&E ×40). (B) High power view of perivascular inflammatory infiltration including neutrophils with quite a few eosinophils and fibrinoid necrosis (H&E ×200). (C) Perivascular Immunoglobulin A deposition in immunofluorescence microscopy as shown by arrow.

Reference

1. Watts RA, Scott DG. Epidemiology of the vasculitides. Semin Respir Crit Care Med. 2004. 25:455–464.

2. Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, et al. Paediatric Rheumatology International Trials Organisation (PRINTO). EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis. 2010. 69:798–806.

3. Dwyer JM, Kenicer K, Thompson BT, Chen D, LaBraico J, Schiefferdecker R, et al. Vasculitis and retinoids. Lancet. 1989. 2:494–496.

4. Reynolds P, Fawcett H, Waldram R, Prouse P. Delayed onset of vasculitis following isotretinoin. Lancet. 1989. 2:1216.

5. Aractingi S, Lassoued K, Dubertret L. Post-isotretinoin vasculitis. Lancet. 1990. 335:362.

6. Epstein EH Jr, McNutt NS, Beallo R, Thyberg W, Brody R, Hirsch A, et al. Severe vasculitis during isotretinoin therapy. Arch Dermatol. 1987. 123:1123–1125.

7. Chochrad D, Langhendries JP, Stolear JC, Godin J. Isotretinoin-induced vasculitis imitating polyarteritis nodosa, with perinuclear antineutrophil cytoplasmic antibody in titers correlated with clinical symptoms. Rev Rhum Engl Ed. 1997. 64:129–131.